Form 4 Tracker
Pacira BioSciences, Inc.
PCRX

17 insider filings · Latest: Jun 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 11, 2026Jun 12 9:07 PMLauren RikerSenior Vice President, Finance
Sale
6,115$23.50$143.7K62,284.242(D)

View →

Jun 4, 2026Jun 5 5:57 PMKristen WilliamsChief Administrative Officer
Sale
10,259$22.27$228.5K167,062(D)

View →

Apr 23, 2026Apr 24 8:41 PMShawn CrossChief Financial Officer
Sale
12,941$25.16$325.6K105,341(D)

View →

Apr 22, 2026Apr 22 8:03 PMShawn CrossChief Financial Officer
Sale
1,500$25.01$37.5K105,341(D)

View →

Apr 21, 2026Apr 22 8:03 PMShawn CrossChief Financial Officer
Sale
2,845$25.01$71.2K105,341(D)

View →

Apr 20, 2026Apr 22 8:03 PMShawn CrossChief Financial Officer
Sale
7,714$25.14$193.9K105,341(D)

View →

Mar 17, 2026Mar 19 5:43 PMJonathan SloninChief Medical Officer
Sale
3,261$22.82$74.4K223,640.175(D)

View →

Mar 17, 2026Mar 19 5:43 PMMark FroimsonDirector
Sale
500$21.81$10.9K20,136(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 12 9:07 PMSamit HirawatDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 12 9:07 PMChristopher ChristieDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 12 9:07 PMThomas G WiggansDirector
Grant/Award
32,675$23.4232,675(D)

View →

Jun 10, 2026Jun 12 9:07 PMAlethia YoungDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 12 9:07 PMMichael J. YangDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 12 9:07 PMMarcelo BigalDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 12 9:06 PMMark FroimsonDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 12 9:06 PMLaura BregeDirector
Grant/Award
10,891$23.4210,891(D)

View →

Apr 23, 2026Apr 24 8:41 PMShawn CrossChief Financial Officer
Option Exercise
12,941$16.45150,000(D)

View →

Apr 22, 2026Apr 22 8:03 PMShawn CrossChief Financial Officer
Option Exercise
1,500$16.45162,941(D)

View →

Apr 21, 2026Apr 22 8:03 PMShawn CrossChief Financial Officer
Option Exercise
2,845$16.45164,441(D)

View →

Apr 20, 2026Apr 22 8:03 PMShawn CrossChief Financial Officer
Option Exercise
7,714$16.45167,286(D)

View →